NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc., trading under ticker BRPA, filed a Form 10-Q with the SEC on November 14, 2019, under accession number 0001654954-19-012962. The vehicle originated as Big Rock Partners Acquisition Corp, a blank check company sponsored by Big Rock Partners and taken public in 2018 with a focus on the healthcare and pharmaceuticals sector. The November 2019 quarterly filing reflects the company's operating status during its SPAC lifecycle, with the Big Rock Partners sponsor team guiding the entity through its search and evaluation phase in the life sciences space. Visit SpacDesk and sign up for full access to BRPA's complete filing history, sponsor details, and deal timeline data.